Displaying 1 - 1 of 1
| Active Ingredient | GLARGINE |
| Therapeutic Class | INSULINS |
| Indications | Diabetes mellitus. For use in patients with Type I Diabetes. |
| Caution |
Local reactions, fat hypertrophy at injection site. Insulin glargine preparations are not bioequivalent ; dose adjustment and close metabolic monitoring is recommended if switching bet More ... |
| Dose Range | Once daily at the same time each day. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |